VOYA Investment Management’s Cytek Biosciences CTKB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$618K	Buy	141,385 +43,555	+45%	+$206K	﹤0.01%	1638
2025 Q4	$494K	Sell	97,830 -18,184	-16%	-$84.4K	﹤0.01%	1760
2025 Q3	$403K	Buy	116,014 +77,702	+203%	+$292K	﹤0.01%	1865
2025 Q2	$130K	Sell	38,312 -41,954	-52%	-$140K	﹤0.01%	2423
2025 Q1	$322K	Buy	80,266 +40,517	+102%	+$210K	﹤0.01%	2082
2024 Q4	$258K	Sell	39,749 -3,547	-8%	-$21.1K	﹤0.01%	2275
2024 Q3	$240K	Buy	43,296 +1,679	+4%	+$9.52K	﹤0.01%	2383
2024 Q2	$232K	Buy	41,617 +1,397	+3%	+$8.39K	﹤0.01%	2394
2024 Q1	$270K	Sell	40,220 -9,241	-19%	-$73.1K	﹤0.01%	2305
2023 Q4	$451K	Buy	49,461 +839	+2%	+$5.28K	﹤0.01%	2130
2023 Q3	$268K	Sell	48,622 -262	-0.5%	-$2.1K	﹤0.01%	2363
2023 Q2	$417K	Sell	48,884 -156,859	-76%	-$1.41M	﹤0.01%	2192
2023 Q1	$1.89M	Buy	205,743 +45,390	+28%	+$488K	﹤0.01%	1377
2022 Q4	$1.64M	Buy	160,353 +27,647	+21%	+$372K	﹤0.01%	1416
2022 Q3	$1.95M	Buy	132,706 +89,829	+210%	+$1.17M	﹤0.01%	1330
2022 Q2	$460K	Buy	+42,877	New	+$427K	﹤0.01%	1886